Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02167854
Title Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan-Kettering Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering at Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memoral Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Rockville Centre Rockville Centre New York 11570 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field